nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Auranofin—psoriatic arthritis	0.527	0.677	CbGbCtD
Gadobenate Dimeglumine—ALB—Prednisone—psoriatic arthritis	0.168	0.215	CbGbCtD
Gadobenate Dimeglumine—ALB—Methotrexate—psoriatic arthritis	0.0842	0.108	CbGbCtD
Gadobenate Dimeglumine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00027	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000269	0.00122	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Triamcinolone—psoriatic arthritis	0.000267	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000266	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000266	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Prednisone—psoriatic arthritis	0.000266	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000265	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Methotrexate—psoriatic arthritis	0.000265	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Methotrexate—psoriatic arthritis	0.000265	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000264	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Prednisone—psoriatic arthritis	0.000264	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000264	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000264	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Triamcinolone—psoriatic arthritis	0.000264	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methylprednisolone—psoriatic arthritis	0.000263	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000261	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Methotrexate—psoriatic arthritis	0.00026	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Dexamethasone—psoriatic arthritis	0.00026	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Betamethasone—psoriatic arthritis	0.00026	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Prednisone—psoriatic arthritis	0.000258	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000257	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000257	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Prednisone—psoriatic arthritis	0.000257	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Dexamethasone—psoriatic arthritis	0.000256	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Betamethasone—psoriatic arthritis	0.000256	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000256	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000255	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Dexamethasone—psoriatic arthritis	0.000255	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Betamethasone—psoriatic arthritis	0.000255	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Prednisone—psoriatic arthritis	0.000254	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Infection—Triamcinolone—psoriatic arthritis	0.000254	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Methotrexate—psoriatic arthritis	0.000254	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methylprednisolone—psoriatic arthritis	0.000253	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Methotrexate—psoriatic arthritis	0.000252	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Shock—Triamcinolone—psoriatic arthritis	0.000252	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Shock—Methylprednisolone—psoriatic arthritis	0.000251	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00025	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00025	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00025	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Prednisolone—psoriatic arthritis	0.00025	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00025	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Prednisone—psoriatic arthritis	0.000249	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000249	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000248	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Prednisone—psoriatic arthritis	0.000248	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Prednisone—psoriatic arthritis	0.000248	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000247	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000247	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Dexamethasone—psoriatic arthritis	0.000245	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Betamethasone—psoriatic arthritis	0.000245	0.00111	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Dexamethasone—psoriatic arthritis	0.000242	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Betamethasone—psoriatic arthritis	0.000242	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Betamethasone—psoriatic arthritis	0.000241	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Dexamethasone—psoriatic arthritis	0.000241	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Dexamethasone—psoriatic arthritis	0.000239	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Betamethasone—psoriatic arthritis	0.000239	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000238	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Pain—Prednisolone—psoriatic arthritis	0.000238	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000235	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000233	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000233	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000232	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000232	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000232	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Infection—Dexamethasone—psoriatic arthritis	0.000231	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Infection—Betamethasone—psoriatic arthritis	0.000231	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00023	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00023	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000229	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000229	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Methotrexate—psoriatic arthritis	0.000229	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Prednisone—psoriatic arthritis	0.000229	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Shock—Dexamethasone—psoriatic arthritis	0.000228	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Shock—Betamethasone—psoriatic arthritis	0.000228	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000228	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000228	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000228	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000226	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Betamethasone—psoriatic arthritis	0.000226	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Prednisone—psoriatic arthritis	0.000226	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000225	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000225	0.00102	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000224	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000224	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Prednisone—psoriatic arthritis	0.000223	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Methotrexate—psoriatic arthritis	0.000222	0.001	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Prednisone—psoriatic arthritis	0.000222	0.001	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Methotrexate—psoriatic arthritis	0.000222	0.001	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Prednisolone—psoriatic arthritis	0.000221	0.000999	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000221	0.000998	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Triamcinolone—psoriatic arthritis	0.00022	0.000997	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00022	0.000995	CcSEcCtD
Gadobenate Dimeglumine—Pain—Triamcinolone—psoriatic arthritis	0.000219	0.000989	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000218	0.000984	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Betamethasone—psoriatic arthritis	0.000217	0.000981	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Dexamethasone—psoriatic arthritis	0.000217	0.000981	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—psoriatic arthritis	0.000216	0.000975	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000215	0.000971	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000214	0.000969	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Prednisone—psoriatic arthritis	0.000214	0.000967	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—psoriatic arthritis	0.000213	0.000965	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000211	0.000956	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000211	0.000956	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Prednisone—psoriatic arthritis	0.000211	0.000953	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Prednisone—psoriatic arthritis	0.000211	0.000953	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000211	0.000953	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00021	0.000951	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Prednisone—psoriatic arthritis	0.00021	0.00095	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000209	0.000947	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000209	0.000944	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000208	0.000942	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000208	0.000942	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Prednisone—psoriatic arthritis	0.000208	0.000942	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—psoriatic arthritis	0.000208	0.000942	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—psoriatic arthritis	0.000207	0.000936	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—psoriatic arthritis	0.000207	0.000936	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000205	0.000927	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000204	0.000924	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000204	0.000924	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Triamcinolone—psoriatic arthritis	0.000203	0.000919	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000203	0.000917	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000203	0.000916	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000202	0.000914	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000202	0.000914	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000202	0.000912	CcSEcCtD
Gadobenate Dimeglumine—Infection—Prednisone—psoriatic arthritis	0.000201	0.000908	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.0002	0.000906	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.0002	0.000906	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—psoriatic arthritis	0.0002	0.000905	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Betamethasone—psoriatic arthritis	0.0002	0.000905	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Dexamethasone—psoriatic arthritis	0.0002	0.000905	CcSEcCtD
Gadobenate Dimeglumine—Shock—Prednisone—psoriatic arthritis	0.000199	0.000899	CcSEcCtD
Gadobenate Dimeglumine—Pain—Dexamethasone—psoriatic arthritis	0.000198	0.000897	CcSEcCtD
Gadobenate Dimeglumine—Pain—Betamethasone—psoriatic arthritis	0.000198	0.000897	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000198	0.000896	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Prednisone—psoriatic arthritis	0.000197	0.000892	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Prednisone—psoriatic arthritis	0.000196	0.000888	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000195	0.000884	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000192	0.000868	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—psoriatic arthritis	0.000191	0.000865	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000191	0.000865	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000191	0.000865	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00019	0.000858	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00019	0.000858	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000188	0.000852	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000188	0.00085	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—psoriatic arthritis	0.000187	0.000844	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—psoriatic arthritis	0.000185	0.000838	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Dexamethasone—psoriatic arthritis	0.000184	0.000834	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Betamethasone—psoriatic arthritis	0.000184	0.000834	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000184	0.000833	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Prednisolone—psoriatic arthritis	0.000184	0.000832	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Triamcinolone—psoriatic arthritis	0.000183	0.00083	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000183	0.00083	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000183	0.00083	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000183	0.00083	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000183	0.00083	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000183	0.000828	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Prednisone—psoriatic arthritis	0.000181	0.000821	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Triamcinolone—psoriatic arthritis	0.000181	0.000818	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—psoriatic arthritis	0.000181	0.000817	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000181	0.000816	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Prednisone—psoriatic arthritis	0.000178	0.000805	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—psoriatic arthritis	0.000176	0.000797	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—psoriatic arthritis	0.000176	0.000797	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—psoriatic arthritis	0.000176	0.000797	CcSEcCtD
Gadobenate Dimeglumine—Rash—Prednisolone—psoriatic arthritis	0.000175	0.000793	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Prednisolone—psoriatic arthritis	0.000175	0.000792	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000175	0.000791	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000175	0.00079	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Prednisone—psoriatic arthritis	0.000174	0.000788	CcSEcCtD
Gadobenate Dimeglumine—Headache—Prednisolone—psoriatic arthritis	0.000174	0.000788	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—psoriatic arthritis	0.000174	0.000787	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Prednisone—psoriatic arthritis	0.000173	0.000782	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—psoriatic arthritis	0.00017	0.00077	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Triamcinolone—psoriatic arthritis	0.000169	0.000765	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000169	0.000764	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000169	0.000763	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—psoriatic arthritis	0.000168	0.000759	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000167	0.000753	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dexamethasone—psoriatic arthritis	0.000166	0.000753	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Betamethasone—psoriatic arthritis	0.000166	0.000753	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000166	0.000749	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000165	0.000747	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Prednisolone—psoriatic arthritis	0.000165	0.000747	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Betamethasone—psoriatic arthritis	0.000164	0.000742	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Dexamethasone—psoriatic arthritis	0.000164	0.000742	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—psoriatic arthritis	0.000164	0.000742	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000163	0.000738	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Triamcinolone—psoriatic arthritis	0.000163	0.000735	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000162	0.000734	CcSEcCtD
Gadobenate Dimeglumine—Rash—Triamcinolone—psoriatic arthritis	0.000161	0.000729	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000161	0.000729	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methylprednisolone—psoriatic arthritis	0.000161	0.000728	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000161	0.000727	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Prednisone—psoriatic arthritis	0.000161	0.000726	CcSEcCtD
Gadobenate Dimeglumine—Headache—Triamcinolone—psoriatic arthritis	0.00016	0.000725	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methylprednisolone—psoriatic arthritis	0.00016	0.000723	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Prednisone—psoriatic arthritis	0.00016	0.000722	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Prednisone—psoriatic arthritis	0.00016	0.000722	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000159	0.000718	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000159	0.000718	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—psoriatic arthritis	0.000158	0.000714	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000154	0.000696	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Dexamethasone—psoriatic arthritis	0.000153	0.000694	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Betamethasone—psoriatic arthritis	0.000153	0.000694	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Triamcinolone—psoriatic arthritis	0.000152	0.000687	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000152	0.000686	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methylprednisolone—psoriatic arthritis	0.000152	0.000685	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000151	0.000681	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—psoriatic arthritis	0.00015	0.000679	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000149	0.000673	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000149	0.000672	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Dexamethasone—psoriatic arthritis	0.000148	0.000667	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Betamethasone—psoriatic arthritis	0.000148	0.000667	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dexamethasone—psoriatic arthritis	0.000146	0.000662	CcSEcCtD
Gadobenate Dimeglumine—Rash—Betamethasone—psoriatic arthritis	0.000146	0.000662	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000146	0.000661	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Betamethasone—psoriatic arthritis	0.000146	0.000661	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000146	0.000659	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—psoriatic arthritis	0.000146	0.000659	CcSEcCtD
Gadobenate Dimeglumine—Headache—Dexamethasone—psoriatic arthritis	0.000145	0.000657	CcSEcCtD
Gadobenate Dimeglumine—Headache—Betamethasone—psoriatic arthritis	0.000145	0.000657	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Prednisone—psoriatic arthritis	0.000145	0.000656	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—psoriatic arthritis	0.000144	0.000653	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Prednisone—psoriatic arthritis	0.000143	0.000647	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000139	0.000629	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Prednisone—psoriatic arthritis	0.000138	0.000625	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000138	0.000625	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Betamethasone—psoriatic arthritis	0.000138	0.000623	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dexamethasone—psoriatic arthritis	0.000138	0.000623	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—psoriatic arthritis	0.000134	0.000607	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Prednisone—psoriatic arthritis	0.000134	0.000604	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000133	0.000604	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000133	0.000604	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Prednisone—psoriatic arthritis	0.000128	0.000581	CcSEcCtD
Gadobenate Dimeglumine—Rash—Prednisone—psoriatic arthritis	0.000127	0.000576	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Prednisone—psoriatic arthritis	0.000127	0.000576	CcSEcCtD
Gadobenate Dimeglumine—Headache—Prednisone—psoriatic arthritis	0.000127	0.000573	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000124	0.000563	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—psoriatic arthritis	0.000121	0.000548	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Prednisone—psoriatic arthritis	0.00012	0.000543	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—psoriatic arthritis	0.000119	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000116	0.000523	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—psoriatic arthritis	0.000112	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—psoriatic arthritis	0.000107	0.000486	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—psoriatic arthritis	0.000106	0.000482	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—psoriatic arthritis	0.000106	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—psoriatic arthritis	0.000106	0.000478	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—psoriatic arthritis	0.0001	0.000454	CcSEcCtD
